Karyopharm Therapeutics Inc. KPTI
0.02 USD -0.02 (-51.75%)
Nov 10, 2026, 1:53 PM EST
0.0189 Day range 0.0299
0.0189 52-week range 10.99
- YTD
- -99.74%
- 1 year
- -99.65%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 146.07M | 145.24M | 146.03M | 157.07M | 209.82M | |
| 140.12M | 139.23M | 141.09M | 151.86M | 206.42M | |
| -90.71M | -119.44M | -129.54M | -142.20M | -98.27M | |
| -196.04M | -76.42M | -143.10M | -165.29M | -124.09M | |
| -17.93 | -14.00 | -18.79 | -30.30 | -24.70 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 60.89M | 62.81M | 53.19M | 136.88M | 197.44M | |
| 108.42M | 164.42M | 240.44M | 358.17M | 305.31M | |
| 401.34M | 350.44M | 376.64M | 374.83M | 384.98M | |
| 233.61M | 194.52M | 177.02M | 179.07M | 180.58M | |
| -292.93M | -186.02M | -136.21M | -16.66M | -79.67M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -75.37M | -127.49M | -92.72M | -149.55M | -107.12M | |
| 43.38M | 95.47M | 7.94M | -104.26M | 141.84M | |
| 30.05M | 41.65M | 1.12M | 193.74M | 73.65M | |
| -1.92M | 9.62M | -83.69M | -60.56M | 108.32M |